PSNL
NASD Personalis, Inc.$16.06 ↑ +0.03 (+0.19%) Trading Up from the previous close of $16.03
- YTD change
- +101.76%
- vs 20-day SMA
- -1.44%
- vs 200-day SMA
- +51.32%
Price ranges
Price & Performance
+9.86 (+159.81%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 70.0% away from all-time highs of $53.46
- PSNL is up 102% since the beginning of the year
- PSNL is up 112% over the past 12 months
- PSNL is down 3% over the past 1 month
- 9% of all PSNL investors are betting against PSNL
PSNL reads neutral: price sits above one of the two key moving averages, the 12-month move is +111.8%.
- Previous minute
- +$0.00
- Last hour
- +$0.02
- Last 5 days
- -1.77%
- vs 8-day SMA
- -1.39%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
